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A fribotic tumor microenvironment promotes progression of cancer. In this study, we utilize a reconstituted
basement membrane mimics Matrigel based three-dimensional organotypic culture (rBM 3-D) to investigate the
mechanisms that mediate the tumor promoting effects of the fibrogenic mediators TGF-β1 and type I collagen
(Col-1) on lung adenocarcinoma cells. Similar to normal alveolar epithelial cells, the well-differentiated lung
adenocarcinoma cells in rBM 3-D culture undergo acinar morphogeneis that features polarized epithelial cell
spheres with a single central lumen. Either TGF-β1 or Col-1 modestly distorts acinar morphogenesis. On the other
hand, TGF-β1 and Col-1 synergistically induce a transition from acinar morphology into stellate morphology that is
characteristic of invasive and metastatic cancer cells. Inhibition of the Src kinase activity abrogates induction of
stellate morphology, activation of Akt and mTOR, and the expression of tumor promoting genes by TGF-β1 and
Col-1. To a similar extent, pharmacological inhibition of mTOR abrogates the cellular responses to TGF-β1 and Col-1.
In summary, we demonstrate that TGF-β1 and Col-1 promote stellate morphogenesis of lung cancer cells. Our
findings further suggest that the Src-Akt-mTOR axis mediates stellate morphogenesis. These findings also indicate
that rBM 3-D culture can serve as an ideal platform for swift and cost-effective screening of therapeutic candidates
at the interface of the tumor and its microenvironment.
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A stiff and fibrotic microenvironment promotes tumor
progression in experimental models [1,2]. Accordingly, a
fibrotic stroma is an independent prognostic indicator of
metastasis and poor prognosis [3]. The majority of such
evidence comes from the investigation of breast cancer in
which the aberrantly stiff extracellular matrix (ECM) is a
well-established risk factor [4]. A recent study has pro-
vided mechanistic insight into the link between the stiff
ECM and progression of breast cancer [5]. Lysyl-oxidase
(LOX) increases the stiffness of ECM via crosslinking
collagen and thereby enhances integrin signaling to pro-
mote invasion and metastasis [5]. Recent advances in lung
cancer research implicate a similar presence and function
of a fibrotic tumor microenvironment. The expression
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reproduction in any medium, provided the orcollagen (Col-1), two of the most potent fibrogenic media-
tors in the lung, is up-regulated in human lung cancer and
overexpression of the two can promote invasion and
metastasis in experimental models of lung cancer [6-8].
Elevated expression of LOX is a biomarker of invasion
and an independent predictor of poor prognosis in
patients with early stage lung adenocarcinoma [9]. In ex-
perimental models of lung cancer, LOX promotes tumor
progression and is targeted by the tumor suppressor gene
LKB1 [10]. However, the molecular mechanisms that me-
diate tumor progression promoted by the fibrotic tumor
microenvironment in the lung remain poorly understood.
A substantial amount of our understanding of the tumor
modulating functions of the tumor microenvironment has
been obtained using three dimensional organotypic culture
based on Matrigel, a reconstituted basement membrane
mimics (rBM 3-D) [11-13]. rBM 3-D culture faithfully
recapitulates salient in vivo properties of the epithelium
from various tissues. The gene expression signature from
rBM 3-D culture of breast cancer cells holds prognosticl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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luable tool to discriminate cancer cells with distinct
tumorigenic potential [15]. In general, the non-invasive
/metastatic breast cancer cells exhibit a mixture of acinar
and mass morphology that features spheroid colonies
(mass) with occasional formation of a single central lumen
(acinus), whereas the invasive/metastatic cancer cells ex-
hibit stellate morphology that features prominent invasive
projections that often bridge multiple cell colonies. More
importantly, rBM 3-D culture provides an ideal system to
reconstitute the tumor microenvironment for mechanistic
investigations. For instance, investigation of Col-1 and its
cognate integrin receptors in rBM 3-D culture of mam-
mary epithelial cells has identified the stiff ECM-integrin
axis as a driving force of initiation and progression of
breast cancer [1,2,5]. Two recent applications of rBM 3-D
culture demonstrate its promise in elucidating molecular
and cell biology of lung epithelial cells. In rBM 3-D culture,
primary human lung alveolar type II cells form alveolar
acini [16]. Similar to mammary epithelial cells, alveolar
acini exhibit salient differentiation features, such as a pola-
rized monolayer of alveolar type II cells and secretion of
surfactant proteins into the central lumen. Because lung
adenocarcinoma generally originates from alveolar type II
cells, it is plausible that dysregulation of alveolar acini is a
pivotal dedifferentiating step in lung tumorigenesis. In
support of this concept, over-expression of the tumor
suppressive PPAR-γ gene can restore alveolar acini in
rBM 3-D organotypic culture of H2122 cells, an aggres-
sive and poorly differentiated human lung adenocar-
cinoma cell line [17].
Recent advances have shown that the tumor associated
stroma and microenvironment are active modulators of
tumorigenesis rather than passive bystanders [18]. The
current study utilizes rBM 3-D organotypic culture to in-
vestigate a link between the behavior of lung cancer cells
and the fribrogenic mediators derived from the tumor
microenvironment.
Results
Morphogenesis of lung cancer cells in rBM 3-D culture
rBM 3-D organotypic culture can promote differentiation
of lung epithelial cells in vitro [16,17]. Therefore, we uti-
lized this model to examine the effects of the fibrogenic
mediators from the tumor microenvironment on morpho-
genesis of lung cancer cells. We established rBM 3-D
culture of 4 human and mouse lung cancer cell lines with
distinct tumorigenic properties. A549 cells are a well-
differentiated non-metastatic human lung adenocarcin-
oma cell line with residual characteristics of alveolar type
II epithelial cells [19]. Similar to normal alveolar type II
epithelial cells, A549 cells formed acini, a polarized cell
sphere with a single central lumen in rBM 3-D culture
(Figure 1A, inset) [16]. Moreover, acini formed by A549cells in rBM 3-D culture resembled the glandular his-
tology observed in the tumors formed by the implanted
A549 cells in mice (Figure 1A). In contrast, A549LC cells,
a more aggressive derivative of A549 cells (see Methods),
exhibited mass morphology that featured irregular cell
clusters void of a central lumen, which resembled the
poorly differentiated H2122 cells in rBM 3-D culture as
reported in a previous study (Figure 1B, inset) [17]. In
congruence, the A549LC xenografts displayed disorga-
nized structure and lacked the glandular histology
(Figure 1B). Moreover, A549LC cells acquired greater
tumorigenic activity than A549 cells in vivo because the
implanted A549LC cells doubled the growth of the
implanted parental A549 cells, 0.21 ± 0.04 g versus 0.1 ±
0.03 g with marginal significance (P value = 0.0678, n = 7,
Additional file 1: Figure S1). We further compared
morphogenesis of two murine lung cancer cell lines mK-
ras-LE and LLC. mK-ras-LE cells were established from a
tumor bearing lung of a K-rasLA1 mouse, a transgenic
strain that develops lung adenocarcinoma with limited
metastasis [20]. Consistent with their well-differentiated
phenotype, mK-ras-LE cells formed acini in rBM 3-D
culture, which correlated with the glandular histology in
the tumor formed by the implanted mK-ras-LE cells
(Figure 1C). In contrast, the metastatic LLC cells exhibited
stellate morphology that is characteristic of metastatic
cancer cells (Figure 1D, inset) [15]. The stellate morph-
ology featured irregular cell clusters with extensive inter-
secting cell protrusions (Figure 1D, inset). In accordance,
the implanted LLC cells grew into irregular cell masses at
the primary site and metastasized to the lung (Figure 1D
and unpublished observations). The correlation of mor-
phogenesis of four lung cancer cell lines in rBM 3-D
culture and histology in vivo indicated that rBM 3-D cul-
ture is an appropriate in vitromodel to assess morphogen-
esis that is relevant to tumorigenic behaviors of lung
cancer cells in vivo.
Src-mediated stellate morphogenesis induced by TGF-β1
and Col-1
Because the tumormicroenvironment is commonly fibrotic
and enriched with fibrogenic mediators, we examined mor-
phogenesis of A549 and A549LC cells in rBM 3-D culture
exposed to various combinations of TGF-β1 and Col-1, two
prominent fibrogenic mediators in the tumor microenvi-
ronment [6-8]. Addition of TGF-β1 (5 ng/ml) or Col-1
(1.5 μg/ml) alone caused little to modest perturbation of
acini as evidenced by distorted cell clusters and partial to
complete filling of central lumens (Figure 2A). Simulta-
neous exposure to TGF-β1 and Col-1 abolished acinar
morphology and induced a transition into stellate morph-
ology that was characteristic of invasive/metastatic cancer
cells (Figures 2A & 1D) [15]. In a similar fashion, A549LC
cells underwent transition from mass morphology into
Figure 1 Distinct growth patterns of lung cancer cell lines in rBM 3-D organotypic culture. Four human and mouse lung cancer cell lines
were cultured in rBM 3-D culture. Morphogenesis of lung cancer cells was visualized by filamentous actin staining and confocal fluorescent
microscopy (insets). The insets of A-C were captured at 400x and part D was captured at 200x because of the larger diameter of LLC cell cluster.
The growth patterns of lung cancer cells in vivo were visualized using H & E staining (main images, 100x). Representative glandular structures are
indicated by arrows in A & C.
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β1 and Col-1 in rBM 3-D culture (Figure 2B).
The Src kinase is a key signal transducer of ECM and
growth factors [21]. We then questioned whether the
Src kinase activity is required for induction of stellate
morphology by TGF-β1 and Col-1. To this end, A549
cells were exposed to TGF-β1 and Col-1 in the presence
or absence of PP2 (5 μM), an Src selective inhibitor.
When compared to the group treated with the DMSO
vehicle, PP2 abrogated induction of stellate morphology
by TGF-β1 and Col-1, but did not restore acinar mor-
phology because the cell colonies were still void of a sin-
gle central lumen (Figure 2C). Similar observations were
made in A549LC cells upon exposure to various combi-
nations of TGF-β1, Col-1, and PP2 (data not shown). To
further confirm a requirement of the Src kinase activity
for induction of stellate morphology by TGF-β1 and
Col-1, we generated two variants of A549LC cells that
were transduced with either a retroviral vector expres-
sing a dominant-negative Src mutant (A549LCdnSrc) or
its backbone vector (A549LCvec). Similar to PP2, the ex-
pression of the dnSrc mutant abolished stellate morph-
ology induced by TGF-β1 and Col-1, whereas A549LCvec’s
response to TGF-β1 and Col-1 was comparable to that of
the parental A549LC cells (Figure 2, B & D). Thesefindings indicated a requirement of the Src kinase activity
for induction of stellate morphology by TGF-β1 and Col-1.
To elucidate the mechanisms underlying induction of
stellate morphology, we examined the expression of three
tumor-promoting genes, namely Myc, LOX, and plas-
minogen activator inhibitor-1 (PAI-1) because of their
established link to TGF-β1 and Col-1 [5,6,8]. The mRNA
levels of these genes were determined using quantitative
RT-PCR in A549 cells under various culture conditions.
TGF-β1 alone induced a robust increase in the expression
of all three genes over the control group (3.6-fold in Myc,
303-fold in PAI-1, and 29.7-fold in LOX) (Figure 3, A-C).
In contrast, Col-1 alone did not cause noticeable alte-
ration in the expression of these genes. Despite the syner-
gistic induction of stellate morphology, combination of
TGF-β1 and Col-1 did not result in synergistic increase in
the expression of these genes (Figure 3, A-C). These find-
ings indicated that activation of the Myc, PAI-1, and LOX
genes were by and large driven by the TGF-β1 pathway
during transition towards stellate morphology. Because
inhibition of Src abolished stellate morphology induced by
TGF-β1 and Col-1, we examined the effects of PP2 on the
induction of Myc, PAI-1, and LOX by TGF-β1 and Col-1
in rBM 3-D culture of A549LC cells. As expected, PP2
substantially reduced the induction of Myc (reduced to
Figure 2 Induction of stellate morphology by TGF-β1 and Col-1. A549 and its more aggressive derivative A549LC cells were cultured in rBM
3-D culture (Mat) with or without supplementation of TGF-β1 and/or Col-1. A) Morphogenesis of A549 cells in various culture conditions were
visualized by filamentous actin staining and confocal fluorescent microscopy. The images were captured at 100x. B) Similar to part A except that
the images were captured from A549LC cells at 200x. C) Phase-contrast microscopy was used to capture images of A549 cells cultured in rBM 3-
D (Mat) exposed to the indicated combinations of TGF-β1, Col-1, and PP2 (100x). D) The variants of A549LC cells, A549LCvec and A549LCdnSrc
were cultured in rBM 3-D (Mat) in the present or absence of TGF-β1+Col-1 and morphogenesis was monitored as described in part C.
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(Figure 3D). PP2 also inhibited TGF-β1-induced expres-
sion of Myc (reduced to 24%), PAI-1 (redcued to 6%), and
LOX (reduced to 8%) (Figure 3E). Similar observations
were made in A549LCvec and A549LCdnSrc cells (data
not shown). These findings indicated a requirement of the
Src kinase activity for induction of the Myc, PAI-1, and
LOX genes by TGF-β1 in rBM 3-D culture.
Activation of the Akt-mTOR axis
Src mediates activation of the Akt-mTOR axis in certain
experimental conditions [22,23]. Because the Src kinase
activity is required for stellate morphogenesis induced
by TGF-β1 and Col-1, we questioned whether the Akt-
mTOR axis was activated by TGF-β1 and Col-1 in an
Src-dependent manner. TGF-β1 alone activated Src inrBM 3-D culture because TGF-β1 increased phospho-
rylation of Src at ser416 (Figure 4A). In contrast, Col-1
did not activate Src in rBM 3-D culture (Figure 4A).
Moreover, a combination of TGF-β1 and Col-1 did not
further increase the levels of Src phosphorylated at
Ser416 (Figure 4A). In a similar fashion, the Akt-mTOR
axis was activated by TGF-β1 regardless of the presence
of Col-1 because Akt became hyper-phosphorylated at
Ser473 and mTOR became hyper-phosphorylated at
Ser2448, a target site of Akt (Figure 4A). To determine
whether the Src kinase activity was required for activa-
tion of the Akt-mTOR axis, we compared phos-
phorylation of Akt and mTOR in A549LCvec and
A549LCdnSrc in rBM 3-D culture exposed to TGF-β1
and Col-1 (Figure 4B). The dominant-negative activity
of the dnSrc mutant was confirmed as A549LCdnSrc
Figure 3 Activated expression of the tumor promoting genes by TGF-β1 in rBM 3-D. Total cell RNA was extracted from A549 cells cultured
in rBM 3-D (Mat) culture exposed to the indicated combinations of TGF-β1 and Col-1. The expression of the selected tumor-promoting genes
was determined using quantitative RT-PCR. Ratios of each mRNA over the housekeeping gene 36B4 were compared across various culture
conditions. A-C) The expression of Myc, PAI-1, and LOX was evaluated, respectively. A fold change was obtained by setting the values from the
control group to one. D) The expression of Myc, PAI-1, and LOX was compared between A549 cells cultured in Mat+TGF-β1+Col-1 with or
without PP2. A fold change was obtained by setting the values from the PP2 minus group to one. E) Similar to part C except that the expression
of Myc, PAI-1, and LOX was compared between A549 cells cultured in Mat+TGF-β1 with or without PP2. Mean and standard deviations were
obtained from three independent experiments. *, **, and *** indicate a P value < 0.05, 0.01, and 0.001, respectively.
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cal adhesion kinase (FAK), a classical target of Src
(Figure 4B) [24]. As expected, A549LCdnSrc cells exhib-
ited a substantial decrease in phosphorylation of Ser473
in Akt (Figure 4B). Consistent with reduced activation
of Akt, A549LCdnSrc exhibited reduced phosphoryl-
ation of Ser2448 in mTOR (Figure 4B). Lastly, we exam-
ined phosphorylation of Thr389 in p70 S6K, a target site
of mTOR. The expression of the dnSrc mutant substan-
tially reduced phosphorylation of Thr389 in p70 S6K.
These findings indicated a requirement of the Src kinase
activity for activation of the Akt-mTOR axis by TGF-β1
and Col-1. These results also prompted us to determinewhether mTOR was required for induction of stellate
morphology by TGF-β1 and Col-1. To this end, A549 cells
were cultured in rBM 3-D culture exposed to TGF-β1 and
Col-1 in the presence or absence of Torin-1 (250 nM), an
mTOR-specific inhibitor [25]. As expected, Torin-1 abro-
gated stellate morphology induced by TGF-β1 and Col-1
(Figure 4B). Moreover, Torin-1 attenuated the gene activa-
tion by TGF-β1 and Col-1 in that induction of the LOX
and Myc genes was nearly abrogated, although induction
of PAI-1 was refractory to Torin-1 (Figure 4C). These
findings indicated that Src-mediated activation of the Akt-
mTOR axis was required for stellate morphogenesis
induced by TGF-β1 and Col-1.
Figure 4 Activation of the Akt-mTOR axis in stellate morphogenesis. A) Total cell protein was extracted from A549 cells in rBM 3-D culture
exposed to the indicated combinations of TGF-β1 and Col-1. The protein levels of total and phosphorylated Src, Akt, and mTOR were determined
using immunoblots. B) Similar to A except that total cell protein was extracted from A549LCvec and A549LCdnSrc cells in rBM 3-D culture
exposed to TGF-β1 and Col-1. The protein levels of total and phosphorylated FAK, Akt, mTOR, and p70 S6K were determined using immunoblots.
C) A549LC cells were cultured in rBM 3D culture supplemented with TGF-β1 and Col-1 in the presence or absence of Torin-1 (250 nM).
Morphogenesis of A549LC cells was monitored for 12 days. Images were captured using phase contrast microscopy. D) The culture condition was
identical to that described in part B. Total cell RNA was extracted from A549 cells. The expression of LOX, PAI-1, and Myc was determined using
quantitative RT-PCR. Ratios of each gene transcript over the housekeeping gene 36B4 were compared across various culture conditions. A fold
change was obtained by setting the values from the control group to one. Mean and standard deviations were obtained from three independent
experiments. * and ** indicate a P value < 0.05 and 0.01, respectively.
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The current study investigates the molecular mecha-
nisms that mediate cancer progression promoted by the
fibrotic tumor microenvironment using rBM 3-D culture
of lung cancer cells. We aim to define the molecular
mechanisms that mediate the tumor-promoting effects
derived from the fibrotic tumor microenvironment.
rBM 3-D culture has been successfully applied to
characterize molecular and cell biology of normal and
transformed mammary epithelial cells for the past two
decades [11-13]. In essence, rBM 3-D culture bears simi-
lar potential for investigation of lung biology because
the lung and the breast share several key developmental
and structural traits, such as branching morphogenesisduring development and formation of alveoli [26]. In-
deed, rBM 3-D culture of normal human lung alveolar
type II epithelial cells promotes expression of the differ-
entiation markers, such as surfactant protein C and
formation of acini, an in vitro mimic of alveoli [16].
More importantly, over-expression of PPAR-γ, a tumor
suppressor gene, can restore formation of acini in a
poorly differentiated human lung cancer cell line in rBM
3-D culture [17]. Our findings strengthen the concept
that rBM 3-D culture can be used to assess invasive and
metastatic potential of lung cancer cells by comparing
morphogenesis of four lung cancer cell lines with dis-
tinct tumorigenic behaviors in vivo. By and large, the
well-differentiated lung adenocaricnoma cells, A549 and
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A549LC and LLC cells exhibit mass and stellate mor-
phology (Figure 1). The diverse growth patterns of these
four lung cancer cell lines in rBM 3-D culture are
congruent to their disparate histology and tumorigenic
potential in vivo (Figure 1). It is noteworthy that rBM
3-D culture reveals distinct morphogenesis between
A549 (acinar morphology) and A549LC (mass mor-
phology), whereas the two cell lines appear nearly identi-
cal in 2-D culture (data not shown). The morphological
difference in rBM 3-D is also congruent to their distinct
histology and tumorigenic activity in vivo (Figure 1, A & B).
With further optimization and validation, rBM 3-D organo-
typic culture can be utilized as a surrogate to qualitatively
and quantitatively assess tumorigenic properties of lung
cancer cells.
One major advantage of rBM 3-D culture is that it
allows assessment of tumor modulating cues derived from
the tumor microenvironment [11-13]. As revealed in our
study, TGF-β1 and Col-1 synergistically induce stellate
morphology, a hallmark feature of invasive/metastatic
cancer cells (Figures 1 & 2) [15]. This combined exposure
may recapitulate the fibrotic tumor microenvironment
in vivo where lung cancer cells are simultaneously and
constantly exposed to a variety of fibrogenic mediators
[6-8]. Induction of stellate morphology by a combination
of TGF-β1 and Col-1 is also consistent with a previous
study in which provisional ECM, such as fibronectin
and Col-1 potentiates epithelial-mesenchymal transition
(EMT) of alveolar type II epithelial cells in response to
TGF-β1 in 2-D culture [27]. Thus, stellate morphology
induced by TGF-β1 and Col-1 can be perceived as a
phenomenon of EMT in rBM 3-D culture, which allows
investigation of EMT of lung cancer cells, a pivotal step
towards invasion/metastasis in the context of ECM. In
support of our notion, characterization of EMT using
rBM 3-D culture has been proposed as a routine protocol
based on initial success of this approach [28].
Our attempt to pinpoint the mediators of the synergis-
tic induction of stellate morphology by TGF-β1 and
Col-1 results in limited success. Nevertheless, we iden-
tify the signaling pathway and target genes activated by
the TGF-β1 arm, which is not sufficient, but required for
transition from acinar to stellate morphology (Figures 2,
3, 4). Specifically, the Src kinase activity is required for
induction of stellate morphology and activation of gene
expression by TGF-β1 in the presence or absence of
Col-1 (Figures 2 & 3). Similarly, the Src kinase activity
appears to be essential for activation of the Akt-mTOR
axis by TGF-β1 in the presence or absence of Col-1
(Figures 2 and 4). Besides the inducible stellate morpho-
genesis, the Src kinase activity appears to be required for
native stellate morphogenesis of the invasive/metastatic
cancer cell lines because inhibition of the Src kinaseactivity abrogates stellate morphogenesis of the invasive/
metastatic LLC, 4T1, and MDA-MB231 cells (unpub-
lished observations).
Despite similar distortion of acinar morphogenesis, only
TGF-β1, but not Col-1 stimulates the expression of the
MYC, LOX, and PAI-1 (Figures 1 & 3). It is conceivable
that Col-1 employs an alternative gene expression pro-
gram to disrupt acinar morphogenesis. In support of this
notion, Col-1 stimulates the expression of the oncogenic
miR-21 gene in rBM 3-D culture, which is not observed in
lung cancer cells exposed to TGF-β1 (unpublished obser-
vations) [29]. Among the TGF-β1-activated tumor
promoting genes, LOX exhibit an Src- and mTOR-
dependence and a strong correlation to stellate morph-
ology (Figures 3 & 4) [9]. These findings suggest a novel
mechanism for the elevated expression of LOX in human
lung cancer in that TGF-β1 induces the expression of
LOX in lung cancer cells via the Src-Akt-mTOR axis. It is
also conceivable that the TGF-β1-induced expression of
LOX in rBM 3-D culture crosslinks the supplemented
Col-1 to substantially increase the stiffness of rBM 3-D
culture and thereby mediates synergistic induction of stel-
late morphology by TGF-β1 and Col-1. Among the three
genes examined upon blockade of Src and mTOR, PAI-1
appears to be refractory to inhibition of mTOR, whereas
inhibition of Src diminishes activation of all three genes
(Figures 3 & 4). This suggests that mTOR mediate only
part of the gene activation program activated by Src upon
exposure to TGF-β1. This observation could also be
attributed to the SMAD3 binding motif in the PAI-1 pro-
moter that induces the expression of PAI-1 through
SMADs, the canonical TGF-β pathway and delivers resist-
ance to blockade of the non-canonical TGF-β pathways,
such as mTOR [30].
In summary, we demonstrate that the fibrogenic media-
tors derived from the tumor microenvironment promote
stellate morphogenesis of lung cancer cells. Our results
further suggest that the Src-Akt-mTOR axis, a group of
promising therapeutic targets in lung cancer, acts as a
signal transducer of the fibrotic tumor microenvironment
[22,23,31]. Our work warrants further investigation to
elucidate the molecular mechanisms that mediate syner-
gistic induction of stellate morphology by TGF-β1 and
Col-1. These findings also strongly suggest that rBM 3-D
culture can serve as an ideal platform for swift and cost-
effective screening of therapeutic candidates at the inter-
face of the tumor and its microenvironment.
Methods
Reagents and plasmids
PP2, an Src specific inhibitor, was purchased from
Calbiochem (San Diego, CA). Matrigel was purchased
from BD Biosciences (Rockville, MD). Rat Col-1 was
purchased from Sigma (St. Louis, MO). Recombinant
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apolis, MN). A dominant-negative chicken Src-K295R
mutant expressing retroviral vector (dnSrc) and its back-
bone (pLNCX) were kindly provided by Dr. Brugge at
Harvard University [32,33]. Torin1, an mTOR-specific
inhibitor was a gift from Dr. Sabatini at MIT [25]. Invitro-
gen (Carlsbad CA) provided the antibodies specific for
total and phosphorylated (Tyr861) FAK. Cell Signaling
(Danvers MA) provided the antibodies specific for total
and phosphorylated Src (Tyr416), Akt (Ser473), mTOR
(Ser2448), and p70 S6K (Thr389).
Cell culture
A549 cells, a human lung adenocarcinoma cell line were
obtained from ATCC (Manassas VA) and cultured as
previously described [34,35]. A549LC cells were derived
from parental A549 cells using a murine model of lung
metastasis [36,37]. Briefly, A549 cells (106 cells/mouse)
were injected via the jugular vein into adult female beige-
SCID mice (Charles River). Four months after injection,
lungs were inspected and one metastatic nodule was
excised, disaggregated and established in culture. The
dnSrc expressing variant of A549LC (A549LCdnSrc) and
its matching backbone vector variant (A549LCvec) were
generated using retroviral transduction as we previously
described [38]. mK-ras-LE cells, a murine lung epithelial
cell line, were established from a tumor bearing lung of a
K-rasLA1 transgenic mouse and cultured in RPMI-1640 as
described elsewhere [20,29]. Lewis lung carcinoma cells
(LLC), a metastatic murine lung cancer cell line, were pur-
chased from ATCC (Manassas, VA) and cultured in
DMEM.
rBM 3-D organotypic culture and image analysis
rBM 3-D organotypic culture was employed because of
the prior success of this approach in characterizing diffe-
rentiation of both primary and transformed lung epithelial
cells [11-13,16,17]. Briefly, the lung cancer cells were
seeded in an overlay fashion on a layer of Matrigel on
day zero. The culture medium containing 4% Matrigel
(volume/volume) was replaced every other day. Formation
of acini was monitored for twelve days prior to harvest for
image, RNA, and protein analyses. The cultured cells were
visualized using fluorescent staining for filamentous actin
with Alexa 488 conjugated phalloidin (Invitrogen, Carlsbad
CA). The images were captured using confocal fluorescent
or phase contrast microscopy as we previously described
[26,39]. In the selected cultures, various combinations
of TGF-β1 (5 ng/ml), Col-1 (1.5 μg/ml), and Torin-1
(250 nM) were added to rBM 3-D culture.
RNA extraction and quantitative RT-PCR
Total cell RNA was extracted from rBM 3-D culture using
TRIzol per the provider’s instructions (Invitrogen, CarlbadCA). The expression of each gene of interest was de-
termined using quantitative RT-PCR on an iCycler (BIO-
RAD, Hercules CA) and compared across the groups as
described else where [40]. The sequences of each pair of
primers were listed in Additional file 1: Table S1.Immunoblots
Total cell protein was extracted using RIPA buffer supple-
mented with Protease and Protein Phosphatase Inhibitor
Cocktails (Sigma, St. Louis MO) after A549 cells and their
variants were extracted from rBM 3-D culture [26]. The
expression of the total and phosphorylated proteins of
interest was determined using immunoblots as described
we previously described [34].Implantation of lung cancer cells
All mouse studies were carried out following the animal
protocol approved by the Institute Animal Care and Use
Committee at Tulane University School of Medicine. Sub-
cutaneous implantation of human and mouse lung cancer
cells (2 × 106 cells/mouse) into male nude and syngeneic
mice (Charles River, Wilmington, MA) was carried out as
we previously described [36,41]. Each group of tumor graft
consisted of 7 mice. Tumor growth was monitored daily
after implantation. The tumor mass was dissected from
mice at four weeks after implantation and processed for
weighing and H&E staining.Statistical analysis
When presented, means and standard deviations were
obtained from 3 independent experiments. A P value be-
tween any two selected groups was determined using
unpaired two-tailed Student's T-test (GraphPad Prism,
Version 5).Additional file
Additional file 1: Table S1. Primers. Figure S1 Tumor growth of
subcutaneously implanted A549 and A549LC cells.
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